A groundbreaking hormone-free male birth control pill, YCT-529, has transitioned from successful preclinical studies in mice to the initiation of human trials. Developed by YourChoice Therapeutics, ...

Getting older isn’t a choice—but feeling stuck in low gear? That’s a different story. As men age, hormone decline drains energy, focus, and drive. Testosterone keeps men sharp, strong, and motivated, ...

For men, it is often taken as a given that muscle mass, vitality, and overall health will decline with age. By offering testosterone replacement therapy in the form of creams, gels, and injections, ...

After decades of false starts, researchers say they are finally making progress on a long-acting and reversible birth control option for men. The experimental product is a hormonal gel that men rub on ...

A recent study published in Scientific Reports investigates the accuracy of a novel artificial intelligence (AI) screening method for male infertility based on serum hormone levels. Study: A new model ...

A hormone-free male birth control pill is undergoing clinical testing for the first time ever. The drug, called YCT-529, has performed incredibly well at limiting the production of sperm in mice and ...

YCT-529 is a retinoic acid receptor-alpha inhibitor designed to prevent sperm production by blocking access to vitamin A. A phase 1 study evaluating the first hormone-free male birth control pill, YCT ...

DENVER--(BUSINESS WIRE)--Posterity Health, the Center of Excellence for Male Care, proudly announces the launch of its innovative Hormone Management Program. The new service is focused on helping ...

NEW YORK (Reuters Health) - Postmenopausal women with low sexual desire levels reported improved sexual function after they were treated with a patch in which the male hormone testosterone was applied ...

Neoadjuvant dynamic marker-adjusted personalized therapy comparing trastuzumab-deruxtecan versus pacli-/docetaxel + carboplatin + trastuzumab + pertuzumab in HER2+ early breast cancer: ...

The etiology of SjD is often attributed to a number of factors, including genetics, hormone profiles, and chronic exposure to pathogens. While the majority of patients with SjD are women and diagnoses ...